20-21705764-G-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001257096.2(PAX1):​c.52G>C​(p.Gly18Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,262,292 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G18A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

PAX1
NM_001257096.2 missense

Scores

2
1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.00600
Variant links:
Genes affected
PAX1 (HGNC:8615): (paired box 1) This gene is a member of the paired box (PAX) family of transcription factors. Members of the PAX family typically contain a paired box domain and a paired-type homeodomain. These genes play critical roles during fetal development. This gene plays a role in pattern formation during embryogenesis and may be essential for development of the vertebral column. This gene is silenced by methylation in ovarian and cervical cancers and may be a tumor suppressor gene. Mutations in this gene are also associated with vertebral malformations. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04851672).
BP6
Variant 20-21705764-G-C is Benign according to our data. Variant chr20-21705764-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1440551.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAX1NM_001257096.2 linkc.52G>C p.Gly18Arg missense_variant Exon 1 of 5 ENST00000613128.5 NP_001244025.1 A0A087WXV5
PAX1NM_006192.5 linkc.52G>C p.Gly18Arg missense_variant Exon 1 of 5 NP_006183.2 P15863-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAX1ENST00000613128.5 linkc.52G>C p.Gly18Arg missense_variant Exon 1 of 5 1 NM_001257096.2 ENSP00000481334.1 A0A087WXV5
PAX1ENST00000398485.6 linkc.52G>C p.Gly18Arg missense_variant Exon 1 of 5 5 ENSP00000381499.2 P15863-1

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151334
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000444
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000198
AC:
22
AN:
1110958
Hom.:
0
Cov.:
31
AF XY:
0.0000246
AC XY:
13
AN XY:
529474
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22920
American (AMR)
AF:
0.00
AC:
0
AN:
8388
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14266
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26778
South Asian (SAS)
AF:
0.00
AC:
0
AN:
20598
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35452
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3204
European-Non Finnish (NFE)
AF:
0.0000225
AC:
21
AN:
934966
Other (OTH)
AF:
0.0000225
AC:
1
AN:
44386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151334
Hom.:
0
Cov.:
32
AF XY:
0.0000271
AC XY:
2
AN XY:
73850
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41364
American (AMR)
AF:
0.00
AC:
0
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3456
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5108
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10444
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000444
AC:
3
AN:
67620
Other (OTH)
AF:
0.00
AC:
0
AN:
2076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Aug 26, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine with arginine at codon 18 of the PAX1 protein (p.Gly18Arg). The glycine residue is weakly conserved and there is a moderate physicochemical difference between glycine and arginine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with PAX1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Benign:1
Feb 07, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.037
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
4.8
DANN
Benign
0.65
DEOGEN2
Benign
0.063
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.024
N
LIST_S2
Benign
0.44
T;T
M_CAP
Pathogenic
0.43
D
MetaRNN
Benign
0.049
T;T
MetaSVM
Uncertain
-0.20
T
MutationAssessor
Benign
-0.81
N;.
PhyloP100
0.0060
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
0.67
N;.
REVEL
Benign
0.21
Sift
Benign
0.44
T;.
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;.
Vest4
0.10
MutPred
0.29
Gain of MoRF binding (P = 0.0211);Gain of MoRF binding (P = 0.0211);
MVP
0.36
MPC
1.6
ClinPred
0.032
T
GERP RS
-0.29
PromoterAI
0.048
Neutral
Varity_R
0.067
gMVP
0.11
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1347724154; hg19: chr20-21686402; API